2012 P4P Tip Sheet. Table of Contents

Size: px
Start display at page:

Download "2012 P4P Tip Sheet. Table of Contents"

Transcription

1 2012 P4P Tip Sheet Table of Contents 1. Adolescent Immunizations 2 2. Childhood Immunizations 3 3. Appropriate Treatment for Children with Upper Respiratory Infection.4 4. Appropriate Testing for Children with Pharyngitis Asthma Medication Ratio.6 6. Avoidance of Antibiotic Treatment for Adults with Acute Bronchitis Use of Imaging Studies for Low Back Pain Human Papillomavirus Vaccine for Female Adolescents (HPV) Chlamydia Screening in Women Evidence-Based Cervical Cancer Screening Coordinated Diabetes Care Eye Exams Coordinated Diabetes Care Blood Pressure Control (<140/90) Coordinated Diabetes Care Cholesterol Management: LDL Screening Coordinated Diabetes Care Cholesterol Management: LDL Control < Coordinated Diabetes Care Nephropathy Monitoring Coordinated Diabetes Care HbA1c Screening Coordinated Diabetes Care HbA1c Control (<8.0%, <7.0%) Coordinated Diabetes Care HbA1c Poor Control (>9.0%) Cholesterol Management for Patients with Cardiovascular Conditions: LDL-C Screening Cholesterol Management for Patients with Cardiovascular Conditions: LDL-C Control Colorectal Cancer Screening Breast Cancer Screening Annual Monitoring for Patients on Persistent Medications Proportion of Days Covered by Medications...24 P4P_Detailed_Tip_Sheet_052012_V1 Page 1

2 1. Adolescent Immunizations The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine and one tetanus, diphtheria toxoids, and acellular petussis vaccine (Tdap) or one tetanus, diphtheria toxoid vaccine (Td) by their 13 th birthday. This measure can be completed by giving one Tdap and one Meningicoccal vaccine at years during a preadolescent well visit. Please note: Age appropriate antigen series must be completed on or before the child s 13 th birthday. The CDC immunization schedule recommends these be completed at age 11 or 12; however, P4P/HEDIS considers vaccines compliant if administered on or before the child s 13 th birthday. If the adolescents thirteenth birthday is March 2, their visit most likely should occur in February, to ensure the antigen series is administered on or before their 13 th birthday. Review the recommended immunization schedule for adolescents from the academy of pediatrics located at: Ensure that physicians document in the medical record if and why a vaccine is contraindicated for the patient. Those with a contraindication will not be included in the denominator for these measures. Exclusions should be identified using the following codes, or documented where a code is not listed. Immunization Exclusion Description ICD-9-CM Diagnosis Description Any particular Anaphylactic reaction to the vaccine or its vaccine components P4P_Detailed_Tip_Sheet_052012_V1 Page 2

3 Childhood Immunizations Percentage of children age 2 years who were identified as having completed the following antigen series by their second birthday: 4 diphtheria, tetanus, and acellular pertussis (DTap/DT) 3 hepatitis B 4 pneumococcal conjugate vaccines (PCV) 3 polio (IPV) 1 chicken pox (VZV) 1 measles, mumps, rubella (MMR) 3 H influenza type B (HiB) Ensuring that every child receives ALL vaccinations on or before the 2 nd birthday. Provide parents with a copy of the Parents Guide to Childhood Immunizations, which can be found at Find immunization recommendations and additional information, including posters you can download at P4P_Detailed_Tip_Sheet_052012_V1 Page 3

4 Appropriate Treatment for Children with Upper Respiratory Infection Percentage of children ages 3 months to 18 years who were given a diagnosis of upper respiratory infection (URI) and were not dispensed an antibiotic prescription. Ensure that the following ICI-9-CM Diagnosis codes are used for URI: o 460 Acute nasopharyngitis (common cold) o 465 URI Advocate aids that assist in improving compliance: o Consider prescribing an over-the-counter (OTC) medication that may help alleviate the patient s symptoms, as many patients expect a prescription from their physician for URI. o Visit to download the 2010 AWARE toolkit, which includes an updated treatment summary for acute respiratory tract infections and tools that can be used in physician practices. Illness/pathogen Indications for antibiotic treatment Treatment Antibiotic Nonspecific cough illness/bronchitis > 90% of cases caused by routine When to treat with an antibiotic: nonspecific cough illness. When to treat with an antibiotic: Presents with prolonged unimproving cough Treatment reserved for B. Pertussis, Macrolides (tetracyclines for children older than 8 years.) respiratory viruses (14 days); should clinically differentiate from pneumonia. Pertussis pneumoniae C. pneumoniae, < 10% cases caused by Bordetella may occur in older children (unusual in those younger than five years). M. pneumoniae pertussis, Chlamydia pneumoniae, or Mycoplasma pneumoniae Bronchiolitis/nonspecific URI > 200 viruses, including rhinoviruses, coronaviruses, denoviruses, respiratory syncytial virus, enteroviruses (coxsackieviruses and echoviruses), influenza viruses, and parainfluenza virus Acute bacterial sinusitis S. pneumoniae, nontypeable H. influenze, M. catarrhalis When to treat with an antibiotic: sore throat, sneezing, mild cough, fever (generally less than 102ºF [39º], for less than three days), rhinorrhea, nasal congestion; self limited (typically 5 to 14 days) When not to treat with an antibiotic: Nearly all cases of acute bacterial sinusitis resolve without antibiotics. Antibiotic use should be reserved for moderate symptoms not improving after 10 days or that worsen after five to seven days, and severe symptoms. When to treat with antibiotic: Diagnosis of an acute bacterial sinusitis may be made with symptoms of viral URI (nasal discharge or daytime cough not improved after 10 days, severe illness with fever, purulen nasal discharge, facial pain) not improving after 10 days or that worsen after 5 to 7 days. Diagnosis may include some or all of the following symptoms or signs: nasal discharge, nasal congestion, facial pressure or pain (especially when unilateral and focused in the region of a particular sinus), post nasal discharge, hyposmia, Adequate fluid intake; may advise rest, OTC medications, humidifier Usual antibiotic duration: 10 days. Failure to respond after 72 hours of antibiotics: reevaluate patient and switch to alternate antibiotic. Fiberoptic endoscopy or sinus aspiration for culture may be necessary P4P_Detailed_Tip_Sheet_052012_V1 Page 4 None First-line therapy Amoxicillin (80 to 90 mg per kg per day) Alternative therapy Amoxicillin/clavulanate (80 to 90 mg per kg per day of amoxicillin component), cefpodoxime, cefuroxime, cefdinir, ceftriaxone For beta-lactam allergy: TMP- SMX (Bactrim, Septra), macrolides, Clindamycin

5 anosmia, fever, cough, fatigue, maxillary dental pain, ear pressure or fullness. (Cleocin) Appropriate Testing for Children with Pharyngitis The percentage of children ages 2 to 18 years who were diagnosed with Pharyngitis, dispensed an antibiotic, and received a group A streptococcus (strep) test for the episode. A higher rate represents better performance (i.e., appropriate testing). Educate all physicians and appropriate staff regarding the standard of care for children with URI: (adapted from Illness/pathogen Indications for antibiotic treatment Treatment Antibiotic Pharyngitis Streptococcus pyogenes, When not to treat with an antibiotic: respiratory viral causes, conjunctivitis, cough, rhinorrhea, diarrhea uncommon with group A streptococcal infection Group A streptococcal infection: Treatment reserved for patients First-line therapy Penicillin V (Veetids); penicillin G benzathine; routine When to treat with an antibiotic: with positive rapid (Bicillin LA) respiratory antigen test or throat Alternative therapy viruses culture S. pyogenes (group A streptococcal infection). Symptoms and signs: Sore throat, fever, headache, nausea, vomiting, abdominal pain, tonsillophyryngeal erythema, exudates, palatal petechiae, tender enlarged anterior cervical lymph nodes. Confoirm diagnosis with throat culture or rapid antigen testing; negative rapid antigen test results should be confirmed with throat culture. Amoxicillin, oral cephalosporins, clindamycin, macrolides Ensure the following ICD-9CM Diagnosis codes are used for children with pharyngitis: Acute pharyngitis: 462 Acute tonsillitis: 463 Streptococcal sore throat: Note: When ICD-9 Code 466.0, acute bronchitis, is appropriate, clinical guidelines do not support the use of antibiotics. Do not empirically treat patients or their siblings, since this may contribute to antibiotic resistance. Advocating aids that assist in improving compliance: o Use updated summary guidelines that indentify the standard of care and recommendation for appropriate testing for children with phayngitis. o Visit to download the 2010 AWARE toolkit, which includes an updated treatment summary for acute respiratory tract infections and tools that can be used in physician practices. FFS Reimbursement Note: Offices receive an additional $7.50 per test, over their capitation. P4P_Detailed_Tip_Sheet_052012_V1 Page 5

6 P4P_Detailed_Tip_Sheet_052012_V1 Page 6

7 Asthma Medication Ratio The percentage of members 5-64 years of age who were identified as having persistent asthma and had a ratio of controller medications to total asthma medication of.50 or greater during the measurement year. Ensuring that ICD-9 code 493.X is used for asthma. Ensuring use of the controller and reliever medications listed in the table below. Type Description Prescription Antiasthmatic combinations dyphllineguaifenesin guaifenesin-theophylline Potassium iodide-theophylline Inhaled steroid budesonideformoterol fluticasone-salmeterol combinations Inhaled corticosteroids beclomethasone flunisolide mometasone Controller budesonide fluticasone CFC free triamcinolone Leukotriene modifiers montelukast zafirlukast zileuton Long acting, inhaled beta-2 aformoterol formoterol salmeterol antagonist Mast cell stabilizer cromolyn nedocromil Methylxanthines aminophylline oxtriphylline dyphylline theophylline Reliever Short-acting, inhaled beta-2 albuterol metaproterenol agonist levalbuterol pirbuterol Monitor medication use to determine if member is utilizing the appropriate ratio of controller to reliever medication. Ensure the following ICD-9-CM Diagnosis codes are used to identify exclusions for this measure (COPD or emphysema): Exclusion Description ICD-9-CM Diagnosis Emphysema 492, 506.4, 518.1, COPD 491.2, 493.2, 496, Cystic fibrosis Acute respiratory failure P4P_Detailed_Tip_Sheet_052012_V1 Page 7

8 Avoidance of Antibiotic Treatment for Adults with Acute Bronchitis The percentage of adult s ages 18 to 64 with a diagnosis of acute bronchitis who were not dispensed an antibiotic prescription. Ensure that ICD-9 Code is used for acute bronchitis. Do not immediately treat bronchitis with antibiotics, since it is viral in origin, unless the patient has chronic lung disease. If you are treating as a bacterial infection, please consider using one of the diagnoses listed below in place of code for acute bronchitis when antibiotics are prescribed: Diagnosis ICD-9-CM Diagnosis Bacterial infection unspecified Otitis media 382 Acute Sinusitis 461 Acute pharyngitis 034.0, 462 Acute tonsillitis 463 Chronic sinusitis 473 Infections of the pharynx, larynx, tonsils, adenoids , 474, , , , , Pneumonia Prescribing an OTC medication that may help alleviate the patient s symptoms, as many patients expect a prescription from their physician for acute bronchitis. Downloading guidelines and provider tools and resources: o Visit to download the 2010 AWARE toolkit, which includes an updated treatment summary for acute respiratory tract infections and tools that can be used in physician practices. P4P_Detailed_Tip_Sheet_052012_V1 Page 8

9 Use of Imaging Studies for Low Back Pain The percentage of members with a primary diagnosis of low back pain that did not have an imaging study (plain X-ray, MRI, CT, scan) within 28 days of the diagnosis. The guidelines for low back pain without neurological finding is to use conservative measures for at least 28 days before embarking on imaging studies. o Download the clinical practice guideline for LBP at Ensure the following codes are used to identify exclusions for LBP: Exclusion Description ICD-9-CM Diagnosis Cancer , , V10 Trauma , , , , , 929, 952, IV drug abuse , 304.4, Neurologic impairment , P4P_Detailed_Tip_Sheet_052012_V1 Page 9

10 Human Papillomavirus Vaccine for Female Adolescents (HPV) The percentage of female adolescents 13 years of age who had three doses of human Papillomavirus (HPV) vaccine by their 13 th birthday. Please note: At least three HPV vaccinations with different dates of service, on or between the member s 9 th and 13 th birthdays. HPV vaccines administered prior to the 9 th or after 13 th birthday cannot be counted. Ensure the following codes are used identify HPV immunizations: Immunization CPT HPV (females only) 90649, Ensure the following code is used to identify exclusions for HPV: Immunization Description ICD-9-CM Diagnosis Any particular Anaphylactic reaction to the vaccine or its vaccine components P4P_Detailed_Tip_Sheet_052012_V1 Page 10

11 Chlamydia Screening in Women The percentage of women ages 16 to 24 who were identified as sexually active and who had at least one test for Chlamydia during the measurement year. Have staff collect a urine specimen for all females ages 16 to 24 before the patient is seen by the physician. The physician can then determine if the patient is appropriate for screening. A urine sample is all that is necessary for screening; a pelvic exam not necessary. For the urine Chlamydia screen, use CPT Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique via Quest lab o If the physician does not have significant information on sexual history, the urine collected should be sent for Chlamydia screening via Quest lab. Evidence shows that 80% of all females 19 years of age and older are sexually active Aids to assist with improving compliance: o Download the CDC Chlamydia fact sheet at It can be distributed to sexually active females ages 16 to 24, as well as used to educate physicians and office staff regarding CHL. The sheet should also be posted in exam rooms and areas where physicians write orders. o Download the CDC 2010 STD treatment guidelines at P4P_Detailed_Tip_Sheet_052012_V1 Page 11

12 Evidence-Based Cervical Cancer Screening for Average-Risk Asymptomatic Women (ECS) Women ages 21 years and older who received cervical cancer screening in accordance with evidence-based standards. Three separate overall rates are calculated for this measure based on the same eligible population: Rate 1: Appropriately Screened Women who were screened for cervical cancer according to evidence-based guidelines. A higher rate indicates better performance. This rate will be publicly reported and scored. Rate 2: Not Screened Women who should have been screened for cervical cancer, but were not, based on the available data. A lower rate indicates better performance. Additional outreach could be done to encourage these women to come in for a Pap test. Rate 3: Screened Too Frequently Women who received more cervical cancer screenings than necessary according to evidence-based guidelines. A lower rate indicates better performance. This provides an educational opportunity to reach out to physicians to reinforce the most current evidence and guidelines, and to discuss potential overuse. Evidenced based guideline: Initiation of cervical cancer screening is recommended approximately 3 years after first sexual intercourse or age 21, which ever comes first. The interval for screening the average risk, asymptomatic woman is every 3 years. Routine screening is NOT recommended for women who have a total hysterectomy for a benign condition unless there was prior history of cervical intraepithelial neoplasia grade 2/3. The routine screening for cervical cancer for women older than 65 is not recommended if they have had 3 or more documented, consecutive, normal results on their last cytology. Recommendations and rationale for screening can be found at Ensure the appropriate codes are used to indicate screening. Appropriate screening is once every three years for patients without the exclusions listed below: Exclusion Description ICD-9- CM Diagnosis Dysplasia Nonspecific abnormal Pap test 795.0, Cervical cancer 180, 233.1, V10.41 Diethylstilestrol (DES) exposure HIV 042, V08, HPV 079.4, , Immunodeficiency, including genetic (congenital) immunodeficiency syndromes 279 Aids to assist with improving compliance: P4P_Detailed_Tip_Sheet_052012_V1 Page 12

13 o Implement a reminder and recall process where physicians send post card reminders to patients indicating with ECS is due. This can also be a telephone call to the patient. For those who are past due for their ECS, another post card reminder or call should be generated. Coordinated Diabetes Care Eye Exams The percentage of members years of age with diabetes (type 1 and type 2) who had a retinal eye exam performed during the measurement year. The standard of care for diabetic retinal exams. o Ensure all diabetics receive one of the following: A retinal or dilated eye exam by an eye care professional (optometrist or ophthalmologist) in the measurement year, or A Negative retinal exam (no evidence of retinopathy) by and eye care professional in the year prior to the measurement year. An eye exam by an ophthalmologist is a covered medical benefit for diabetics. Some members are used to going to an eye care professional outside of the medical group. Once a diagnosis of diabetes is established, refer the patient to the group s ophthalmologist for regular care. By doing so, you increase the data capture and improve your rates, while ensuring proper care. Ensure the following codes are used to identify diabetes: 250.XX Ensue that the following codes are used to identify eye exams: CPT CPT Category II HCPCS ICD-9-CM ICD-9-CM Procedure Diagnosis 67028, 67030, 67031, 67036, , 67101, 67105, 67107, 67108, 67110, 67112, 67113, 67121, 67141, 67145, 67208, 67210, 67218, 67220, 67221, 67227, 67228, 92002, 92004, 92012, 92014, 92018, 92019, 92225, 92226, 92230, 92235, 92240, 92250, 92260, , , F, 2024F 2026F, 3072F S0620, S0621, S0625**, S3000 V , 14.9, , 95.11, 95.12, Ensure that all diabetic patients receive an annual retinal eye exam. Visit and download patient education materials regarding diabetic eye care. P4P_Detailed_Tip_Sheet_052012_V1 Page 13

14 Coordinated Diabetes Care: Blood Pressure Control (<140/90) The percentage of patients ages 18 to 75 years with type 1 and type 2 diabetes whose blood pressure is <140/90. NOTE: The last BP reading of the year counts toward this measure. It is important to keep track of your diabetics throughout the year and take action when the BP is 140/90 or greater. Following CPT II codes can be used to submit BP reading via claims/encounter submission process: CPT II 3074F 3075F 3077F 3078F 3079F 3080F Description Most recent systolic blood pressure less than 130 mm Hg Most recent systolic blood pressure mm Hg Most recent systolic blood pressure greater than or equal to 140 mm Hg Most recent diastolic blood pressure less than 80 mmg Hg Most recent diastolic blood pressure mmg Hg Most recent diastolic blood pressure greater than or equal to 90 mm Hg Ensure that action is taken when the BP is 140/90 or greater. Ensure the following codes are used to identify diabetes: 250.XX Download information regarding diabetes and blood pressure control, as well as diabetes in general, at and Note: A BP of 140/90 is not compliant. The reading must be less than the target BP, such as 138/88. P4P_Detailed_Tip_Sheet_052012_V1 Page 14

15 Coordinated Diabetes Care: Cholesterol Management LDL Screening The percentage of patients ages 18 to 75 years with type 1 and type 2 diabetes who had an LDL screening during the measurement year. Ensure LDL screening occurs at least annually. Ensure the following codes are used to identified diabetes: 250.XX Download information regarding diabetes and LDL screening, as well as diabetes in general, at and Aids to assist with improving compliance: o Send post card reminders to patients from their physician indication when LDL screening is due. Include a lab order sheet with the post card reminder so that the patient can have lab tests completed prior to seeing their physician. Phone call reminders may also be used, but you will need to make arrangements for the patient to pick up the voucher/order sheet. o Develop and distribute patient education tools specific to this measure. P4P_Detailed_Tip_Sheet_052012_V1 Page 15

16 Coordinated Diabetes Care: Cholesterol Management LDL Control <100 The percentage of patients ages 18 to 75 years with type 1 and type 2 diabetes who had LDL-C control <100 mg/dl. NOTE: The last screening of the year counts toward this measure. It is important to keep track of your diabetics throughout the year and take action when the LDL is 100 or greater. Ensure that action is taken when LDL is 100 or greater. Ensure the following codes are used to identify diabetes: 250.XX Download information regarding diabetes and LDL screening, as well as diabetes in general, at and NOTE: In order to pass on this measure, the LDL must be 99 or less Aids to assist with improving compliance: o Develop a medication sheet that can be customized for each patient, listing the meds they are currently taking and when they should take them. o If appropriate, recommend these patients to a dietician or nutritional consultant who can educate them on a low cholesterol diet and assist them with meal planning. o Send post card reminders to patients from their physician indicating when LDL screening is due. Include a lab order sheet with the post card reminder, so that the patient can have LDL screening completed prior to seeing their physician. Phone call reminders may also be used, but you will need to make arrangements for the patient to pick up the voucher/order sheet. P4P_Detailed_Tip_Sheet_052012_V1 Page 16

17 Coordinated Diabetes Care: Nephropathy Monitoring The percentage of patients ages 18 to 75 years with type 1 and type 2 diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement year. Ensure annual Nephropathy screening test for all diabetics (Urine microalbumin). Aids to assist with improving compliance: o Post information regarding the standard of care for monitoring diabetic nephropathy in treatment/exam rooms and areas where physicians write orders. o Download educational documents that can be used to educate diabetics at and o Send post card reminders to patients from their physician indicating when nephropathy monitoring is due. Include a lab order sheet with the post card so that the patient can have lab test completed prior to seeing their physician. Phone call reminders may also be used, but you will need to make arrangements for the patient to pick up the voucher/order sheet. P4P_Detailed_Tip_Sheet_052012_V1 Page 17

18 Coordinated Diabetes Care: HbA1c Screening The percentage of patients ages 18 to 75 years with type 1 and type 2 diabetes who had Hemoglobin A1c (HbA1c) screening during the measurement year. Ensure annual HbA1c screening test for all diabetics. Ensure the following codes are used to identify diabetes: 250.XX Aids to assist with improving compliance: o Post information regarding the standard of care for HbA1c screening in treatment/exam rooms and areas where physicians write orders. o Download educational document that can be used to educate diabetics at and o Send post card reminders to patients from their physician indicating when HbA1c screening is due. Include a lab order sheet with the post card so that the patient can have HbA1c screening completed prior to seeing their physician. Phone call reminders may also be used, but you will need to make arrangements for the patient to pick up the voucher/order sheet. o Consider referring patients to a health education program for diabetic patients that addresses screening and control. P4P_Detailed_Tip_Sheet_052012_V1 Page 18

19 Coordinated Diabetes Care: HbA1c Control (<8.0%, <7.0%) The percentage of patients ages 18 to 75 years with type 1 and type 2 diabetes who were tested during the measurement year and identified as having a HbA1c <7 and those with a HbA1c <8. NOTE: The last screening of the year counts toward this measure. It is important to keep track of your diabetics throughout the year and take action when the HbA1c is out of compliance. Ensure that action is taken when HbA1c is >7% Aids to assist with improving compliance: o Post information regarding HbA1c control in treatment/exam rooms and areas where physicians write orders. o Download educational documents that can be used to educate diabetics at and o Develop a medication sheet that can be customized for each patient, listing the meds they are currently taking and when they should take them. o If appropriate, recommend diabetic patients to a dietician or nutritional consultant who can educate them on a diabetic diet and assist them with meal planning. o Consider a referral to endocrinology for insulin initiation. P4P_Detailed_Tip_Sheet_052012_V1 Page 19

20 Coordinated Diabetes Care: HbA1c Poor Control (>9.0%) The percentage of patients ages 18 to 75 years with type 1 and type 2 diabetes who had each screening completed during the measurement year and identified as having HbA1c poor control (>9.0%). NOTE: The last screening of the year counts towards this measure. It is important to keep track of your diabetics throughout the year and take action when the HbA1c is over 9.0% Ensure that action is taken when HbA1c is >9% o If HbA1c is >9, check to see if insulin is prescribed. If not, the next therapeutic step is probably to initiate insulin therapy Ensure the following codes are used to identify diabetes: 250, 357.2, 362.0, , Aids to assist with improving compliance: o Post information regarding HbA1c control in treatment/exam rooms and areas where physicians write orders. o Download educational documents that can be used to educate diabetics at and o Develop a medication sheet that can be customized for each patient, listing the meds they are currently taking and when they should take them. o If appropriate, recommend diabetic patients to a dietician or nutritional consultant who can educate them on a diabetic diet and assist them with meal planning. o Consider a referral to endocrinology for insulin initiation. P4P_Detailed_Tip_Sheet_052012_V1 Page 20

21 Cholesterol Management for Patients with Cardiovascular Conditions: LDL-C Screening The percentage of members age 18 to 75 years who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) or who had a diagnosis of ischemic vascular disease (IVD), who had LDL-C screening completed during the measurement year. Ensure members with cardiovascular conditions are screened for LDL-C test at least annually. Cholesterol Management for Patients with Cardiovascular Conditions: LDL-C Control (< 100 mg/dl) The percentage of members age 18 to 75 years who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) or who had a diagnosis of ischemic vascular disease (IVD), who had LDL Control <100 during the measurement year. Note: The last LDL-C value of the year counts toward this measure. Ensure LDL-C must be < 100, which is 99 is or less. Take action when LDL is 100 or greater. Aids to assist with improving compliance: o Post information regarding LDL-C screening for patients with cardiovascular conditions in treatment/exam rooms and areas where physicians write orders. o Send post card reminders to patients from their physician indicating when LDL screening is due. Include a lab order sheet with the post card reminder so that the patient can have the LDL screening completed prior to seeing their physician. Phone call reminders my also be used, but you will need to make arrangements for the patient to pick up the voucher/order sheet. o If appropriate, recommend these patients to a dietician or nutritional consultant who can educate them on low cholesterol diet and assist them with meal planning. P4P_Detailed_Tip_Sheet_052012_V1 Page 21

22 Colorectal Cancer Screening (COL) The percentage of adults 50 to 75 who had appropriate screening for colorectal cancer during the measurement year, or the year prior to the measurement year. Colorectal Cancer screening can be completed by: o Fecal occult blood test (FOBT) during the measurement year. Regardless of FOBT type, guaiac (gfobt) or immunochemical (ifobt), assume that the required number of samples was returned. o Flexible sigmoidoscopy during the measurement year of the four years prior to the measurement year. o Colonoscopy during the measurement year or the nine years prior to the measurement year. Review information regarding colorectal screening, including the types of screening, that can be found on the National Cancer Institute website at Use aids to assist with improving compliance: o Post information regarding the standard of care for COL, such as the table and types of COL listed above, in treatment/exam rooms and areas where physicians write orders. o Implement a reminder and recall process where physicians send post cared reminders to patients indicating when COL is due. This can also be a telephone call to the patient. For those who are past due for their screening, another post card reminder or call should be generated. A registry can be instrumental in generating patient reminders. o Develop and distribute patient education tools specific to this measure. P4P_Detailed_Tip_Sheet_052012_V1 Page 22

23 Breast Cancer Screening (BCS) The percentage of women ages 40 to 69 who had a mammogram to screen for breast cancer during the measurement year of the year prior. Review the American Cancer Society Guidelines for Early Breast Cancer Detection, 2003 at Send post card reminders to patients from their physician indicating when BCS is due. Include a referral with the post card so that the patient can have the mammogram completed prior to seeing their physician. Phone call reminders may also be used. Identify and report members who have bad a bilateral mastectomy. P4P_Detailed_Tip_Sheet_052012_V1 Page 23

24 Annual Monitoring for Patients on Persistent Medications The percentage of members ages 18 years and older who receive at least a 180-day supply of ambulatory medication therapy for a select therapeutic agents during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year. For each product line, report each of the three rates separately and as a total rate. At least one serum potassium (K) and either a serum creatinine (SCr) or a blood urea nitrogen (BUN) therapeutic monitoring test in the measurement year is considered a monitoring event. Annual monitoring for members on angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB) Annual monitoring for members on digoxin Annual monitoring for members on diuretics Annual monitoring for members on anticonvulsants o Appropriate testing for patients on ACE inhibitors, Digoxin and diuretics is a serum potassium and either a serum creatinine or serum blood urea nitrogen o Appropriate testing for members on anticonvulsants is a serum level of the anticonvulsant Implement a reminder and recall process where physicians send post card reminders to patients indicating that they should come in for a check-up and blood work, or send a letter to have patient have blood work done and follow-up as appropriate. P4P_Detailed_Tip_Sheet_052012_V1 Page 24

25 Proportion of Days Covered by Medications The percentage of members 18 years of age and older who met the Proportion of Days Covered (PDC) threshold of 80% for select medications during the measurement period. Proportion of Days Covered for Angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB): Members who filled at least two prescriptions for an ACEI/ARB or ACEI/ARB combination on two unique dates of service during the measurement period. Proportion of Days Covered for Statins: Members who filled at least two prescriptions for statin or statin combination on two unique dates of service during the measurement period. Proportion of Days Covered for Oral Diabetes Medications: Members who filled at least two prescriptions for any oral diabetes medication on two unique dates of service during the measurement period. Perform medication reconciliation at each visit. Note: Refer to the IHA website for a comprehensive list of medications and associated codes. P4P_Detailed_Tip_Sheet_052012_V1 Page 25

2010 QARR QUICK REFERENCE GUIDE Adults

2010 QARR QUICK REFERENCE GUIDE Adults 2010 QARR QUICK REFERENCE GUIDE Adults ADULT MEASURES (19 through 64 years) GUIDELINE HEDIS COMPLIANT CPT/ICD9 CODES DOCUMENTATION TIPS Well Care Access to Ambulatory Care Ensure a preventive or other

More information

AETNA BETTER HEALTH OF MISSOURI

AETNA BETTER HEALTH OF MISSOURI Aetna Better Health of Missouri 10 South Broadway, Suite 1200 St. Louis, MO 63102 800-566-6444 AETNA BETTER HEALTH OF MISSOURI HEDIS Quick Reference Billing Guide 2014 Diagnosis and/or procedure codes

More information

Care Gap Care Reminder Description Reference 900-2035-1210. Cardiovascular Persistence of Beta- Blocker Treatment After a Heart Attack (PBH)

Care Gap Care Reminder Description Reference 900-2035-1210. Cardiovascular Persistence of Beta- Blocker Treatment After a Heart Attack (PBH) Below is a list of the current Care Reminders shown in the Patient Care Summary Clinical Messaging section of the Availity web portal. These Florida Blue clinical alerts are based on claim data and are

More information

MEASURING CARE QUALITY

MEASURING CARE QUALITY MEASURING CARE QUALITY Region November 2015 For Clinical Effectiveness of Care Measures of Performance From: Healthcare Effectiveness Data and Information Set (HEDIS ) HEDIS is a set of standardized performance

More information

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)

More information

A Detailed Data Set From the Year 2011

A Detailed Data Set From the Year 2011 2012 HEDIS 2012 A Detailed Data Set From the Year 2011 Commercial Product We are pleased to present the AvMed HEDIS 2012 Report, a detailed data set designed to give employers and consumers an objective

More information

ABELMed EHR-EMR/PM version 12, an ONC HIT 2014 Edition Complete EHR, has been certified for the following 42 clinical quality measures (CQMs).

ABELMed EHR-EMR/PM version 12, an ONC HIT 2014 Edition Complete EHR, has been certified for the following 42 clinical quality measures (CQMs). ABELMed EHR-EMR/PM version 12, an ONC HIT 2014 Edition Complete EHR, has been certified for the following 42 clinical quality measures (CQMs). The information contained in this document is also available

More information

HEdis Code Quick Reference Guide Disease Management Services

HEdis Code Quick Reference Guide Disease Management Services HEdis Code Quick Reference Guide Disease Management Services Respiratory Conditions Appropriate Testing for Children With Pharyngitis (ages 2-18) [Commercial, Medicaid] Appropriate Treatment (no antibiotic)

More information

SUMMARY TABLE OF MEASURE CHANGES

SUMMARY TABLE OF MEASURE CHANGES Summary Table of Measure 1 SUMMARY TABLE OF MEASURE CHANGES Guidelines for Physician Measurement Effectiveness of Preventive Care Guidelines for Physician Effectiveness of Care Adult BMI Assessment Weight

More information

1. ML is a 14-month-old girl diagnosed with acute otitis media. She presented to the pediatric

1. ML is a 14-month-old girl diagnosed with acute otitis media. She presented to the pediatric 1 Chapter 72, Self-Assessment Questions 1. ML is a 14-month-old girl diagnosed with acute otitis media. She presented to the pediatric clinic today with a fever of 102.4 F (39.1 C) and tugging of her right

More information

Healthcare Effectiveness Data and Information Set (HEDIS ) Guide

Healthcare Effectiveness Data and Information Set (HEDIS ) Guide Healthcare Effectiveness Data and Information Set (HEDIS ) Guide Clinical ALL ADULTS Access to preventive/ ambulatory health services Smoking and Tobacco Use Cessation [S] Aspirin Use and Discussion [S]

More information

HEDIS Code Quick Reference Guide Preventive/Ambulatory Services

HEDIS Code Quick Reference Guide Preventive/Ambulatory Services HEDIS Code Quick Reference Guide Preventive/Ambulatory Services Child/Adolescent Care Well-Child Visits in the First 15 Months of Life [Commercial, Medicaid] Well-Child Visits in the Third, Fourth, Fifth

More information

AAP Meaningful Use: Becoming a Meaningful User An Outpatient Checklist

AAP Meaningful Use: Becoming a Meaningful User An Outpatient Checklist AAP Meaningful Use: Becoming a Meaningful User An Outpatient Checklist On July 13, 2010, the US Centers for Medicare and Medicaid Services (CMS) released a Final Rule establishing the criteria with which

More information

Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use

Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use Clinical Quality Measures Clinical quality measures have been defined

More information

2016 HEDIS 1 Measures Healthcare Effectiveness Data and Information Set

2016 HEDIS 1 Measures Healthcare Effectiveness Data and Information Set 2016 HEDIS 1 Measures Healthcare Effectiveness Data and Information Set *Measures collected with medical record review. Red= new/addition to measures Blue= Medicare only Prevention and Screening Measure

More information

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate

More information

Appropriate Treatment for Children with Upper Respiratory Infection

Appropriate Treatment for Children with Upper Respiratory Infection BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:

More information

2016 HEDIS /QRS/QARR/EES Physician Documentation Guidelines and Administrative Codes

2016 HEDIS /QRS/QARR/EES Physician Documentation Guidelines and Administrative Codes 2016 HEDIS /QRS/QARR/EES Physician Documentation Guidelines and Administrative Codes This document contains a description of HEDIS and other quality of care measures and includes suggestions and/or recommendations

More information

Test Procedure for 170.304 (j) Calculate and Submit Clinical Quality Measures

Test Procedure for 170.304 (j) Calculate and Submit Clinical Quality Measures Test Procedure for 170.304 (j) Calculate and Submit Clinical Quality Measures This document describes the draft test procedure for evaluating conformance of complete EHRs or EHR modules 1 to the certification

More information

HEDIS Provider Quick Reference Guide. HUSKY Medical ASO (CHNCT)

HEDIS Provider Quick Reference Guide. HUSKY Medical ASO (CHNCT) HEDIS Provider Quick Reference Guide HUSKY Medical ASO (CHNCT) Contents Children and Adolescent Measures... 4 Measure: Well-Child Visits First 15 Months of Life (W15)... 4 Measure: Childhood Immunizations

More information

Total Health Quality Indicators For Providers 2015

Total Health Quality Indicators For Providers 2015 Total Health Quality Indicators For Providers 2015 Adult- Preventive Measure Test/Procedure Parameters Frequency CPT/HCPCS CPT II ICD-9 BMI Assessment BMI Recording 18-74 yrs Yearly G8417, G8418, G8420

More information

2016 HEDIS & Quality Assurance Reporting Requirements Measures Provider Reference Guide

2016 HEDIS & Quality Assurance Reporting Requirements Measures Provider Reference Guide 2016 HEDIS & Quality Assurance Reporting Requirements Measures Provider Reference Guide HEDIS Measure: Test/Care Needed for Compliance Adult BMI Assessment Individuals ages 18-74 Documentation of BMI and

More information

Ohio Health Homes Learning Community Meeting. Overview of Health Homes Measures

Ohio Health Homes Learning Community Meeting. Overview of Health Homes Measures Ohio Health Homes Learning Community Meeting Overview of Health Homes Measures Tuesday, March 5, 2013 Presenter: Amber Saldivar, MHSM Associate Director, Informatics Analysis Health Services Advisory Group,

More information

Prevents future health problems. You receive these services without having any specific symptoms.

Prevents future health problems. You receive these services without having any specific symptoms. Preventive Care To help you live the healthiest life possible, we offer free preventive services for most Network Health members. Please refer to your member materials, which you received when you enrolled

More information

Radiology Business Management Association Technology Task Force. Sample Request for Proposal

Radiology Business Management Association Technology Task Force. Sample Request for Proposal Technology Task Force Sample Request for Proposal This document has been created by the RBMA s Technology Task Force as a guideline for use by RBMA members working with potential suppliers of Electronic

More information

Preventive Health Services

Preventive Health Services understanding Preventive Health Services For the most current version of this document, visit www.wellwithbluemt.com or www.bcbsmt.com. Preventive health services include evidence-based screenings, immunizations,

More information

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES Summary Table of Measures, Product Lines and Changes 1 SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES General Guidelines for Data Collection and Reporting Guidelines for Calculations and Sampling

More information

Many of the changes that have been made to this final rule were directly responsive to CMA s comments.

Many of the changes that have been made to this final rule were directly responsive to CMA s comments. On July 13, 2010, the Centers for Medicare & Medicaid Services (CMS) released the final rule defining meaningful use of an electronic health record (EHR) system. The original version of this rule was released

More information

2013 ACO Quality Measures

2013 ACO Quality Measures ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating

More information

HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications

HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications Superior HealthPlan strives to provide quality healthcare to our membership as measured through HEDIS quality metrics.

More information

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene Stage 1 Meaningful Use for Specialists NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene 1 Today s Agenda Meaningful Use Overview Meaningful Use Measures Resources Primary

More information

Meaningful Use: Stage 1: Functional Measures Eligible Professionals (EPs)

Meaningful Use: Stage 1: Functional Measures Eligible Professionals (EPs) Meaningful Use: Stage 1: Functional Measures Eligible Professionals (EPs) What is Meaningful Use? American Recovery and Reinvestment Act of 2009/Health Information Technology for Economic and Clinical

More information

A COMPARISON OF MEDI-CAL MANAGED CARE P4P MEASURE SETS

A COMPARISON OF MEDI-CAL MANAGED CARE P4P MEASURE SETS A COMPARISON OF MEDI-CAL MANAGED CARE P4P MEASURE SETS The matrix below provides a comparison of all measures included in Medi-Cal P4P programs and the measures includes in DHCS s External Accountability

More information

Commercial Business Medical Cost Target Measurement Period Handbook- For Enhanced Personal Health Care Measurement Period beginning: 01/01/16

Commercial Business Medical Cost Target Measurement Period Handbook- For Enhanced Personal Health Care Measurement Period beginning: 01/01/16 Commercial Business Medical Cost Target Measurement Period Handbook- For Enhanced Personal Health Care Measurement Period beginning: 01/01/16 CBMCT Version 010116 V1 Introduction: Welcome to your Commercial

More information

11/2/2015 Domain: Care Coordination / Patient Safety

11/2/2015 Domain: Care Coordination / Patient Safety 11/2/2015 Domain: Care Coordination / Patient Safety 2014 CT Commercial Medicaid Compared to 2012 all LOB Medicaid Quality Compass Benchmarks 2 3 4 5 6 7 8 9 10 Documentation of Current Medications in

More information

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012 Psychiatrists and Reporting on Meaningful Use Stage 1 August 6, 2012 Quick Overview Functional Measures Providers (tracked by NPI) must report on 15 core objectives and associated measures and 5 objectives

More information

SUMMARY TABLE OF MEASURE CHANGES

SUMMARY TABLE OF MEASURE CHANGES SUMMARY TABLE OF MEASURE CHANGES Measure Name Effectiveness of Preventive Care Adult BMI Assessment Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents Childhood

More information

IHS Clinical Reporting System

IHS Clinical Reporting System RESOURCE AND PATIENT MANAGEMENT SYSTEM IHS Clinical Reporting System (BGP) Version 12.1 Office of Information Technology (OIT) Division of Information Resource Management Albuquerque, New Mexico Revision

More information

Preventive health guidelines As of May 2014

Preventive health guidelines As of May 2014 To learn more about your plan, please see anthem.com/ca. To learn more about vaccines, please see the Centers for Disease Control and Prevention (CDC) website: cdc.gov. Preventive health guidelines As

More information

Preventive Care Services Health Care Reform The following benefits are effective beginning the first plan year on or after Sept.

Preventive Care Services Health Care Reform The following benefits are effective beginning the first plan year on or after Sept. Coding Summary for Providers NOTE THE FOLLOWING: The purpose of this document is to provide a quick reference of the applicable codes for UnitedHealthcare plans that cover preventive care services in accordance

More information

Meaningful Use Stage 2: Important Implications for Pediatrics

Meaningful Use Stage 2: Important Implications for Pediatrics Meaningful Use Stage 2: Important Implications for Pediatrics Glossary of Acronyms MU CQM EHR CEHRT EPs CAHs e-rx CPOE emar ONC CMS HHS Meaningful Use Clinical quality measure Electronic health record

More information

Take advantage of preventive care to help manage your health

Take advantage of preventive care to help manage your health Take advantage of preventive care to help manage your health Preventing disease and detecting health issues at an early stage, if they occur, are important to living a healthy life. Following these recommended

More information

Preventive health guidelines As of May 2015

Preventive health guidelines As of May 2015 Preventive health guidelines As of May 2015 What is your plan for better health? Make this year your best year for wellness. Your health plan may help pay for tests to find disease early and routine wellness

More information

Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method

Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method Stage 1 Meaningful Use Criteria Physicians must meet all 15 Core Set objectives and measures and five of the 10 Menu Set objectives and measures. They also must report clinical quality measures (see separate

More information

Colorado Medicaid HEDIS 2014 Results STATEWIDE AGGREGATE REPORT

Colorado Medicaid HEDIS 2014 Results STATEWIDE AGGREGATE REPORT Colorado Medicaid HEDIS 2014 Results STATEWIDE AGGREGATE REPORT December 2014 This report was produced by Health Services Advisory Group, Inc. for the Colorado Department of Health Care Policy and Financing.

More information

Preventive Health Guidelines

Preventive Health Guidelines Preventive Health Guidelines As of April 2010 What is your plan for better health? Make this year your best year for overall wellness. Your health benefits plan may cover early detection screenings and

More information

Measure Name: URI Treatment without Antibiotics for Children Measure Code: URI Lab Data: N

Measure Name: URI Treatment without Antibiotics for Children Measure Code: URI Lab Data: N Measure Name: URI Treatment without Antibiotics for Children Owner: NCQA (URI) Measure Code: URI Lab Data: N Rule Description: General Criteria Summary The percentage of children 3 months -18 years of

More information

ProviderReport. Message from the CEO. Provider Relations adds Provider Partnership team

ProviderReport. Message from the CEO. Provider Relations adds Provider Partnership team ProviderReport Message from the CEO We recognize the important role our providers play in ensuring member access to high quality services. Our success is built on the philosophy that quality healthcare

More information

The Kroger Pharmacy Vaccine Administration Training Program Self-Study Quiz

The Kroger Pharmacy Vaccine Administration Training Program Self-Study Quiz The Kroger Pharmacy Vaccine Administration Training Program Self-Study Quiz Name: Date: Score: Please darken the letter on the Answer Sheet (last page) that corresponds to the correct answer, and bring

More information

Preventive health guidelines

Preventive health guidelines Preventive health guidelines As of May 2015 What is your plan for better health? Make this year your best year for wellness. Your health plan may help pay for tests to find disease early and routine wellness

More information

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly

More information

Health Care Reform: Using preventive care for a healthier life

Health Care Reform: Using preventive care for a healthier life HorizonBlue.com Health Care Reform: Using preventive care for a healthier life Horizon Blue Cross Blue Shield of New Jersey is committed to empowering our members with access to preventive services to

More information

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents BMI Percentile (Total)

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents BMI Percentile (Total) Appendix C: New Performance Measures DOM Performance Measures Relevant HEDIS Measure(s) HEDIS 2012 Benchmark 50 th Percentile The 50 th percentile benchmarks are an indicator that half of the health plans

More information

Preventive Care Coverage Wondering what preventive care your plan covers?

Preventive Care Coverage Wondering what preventive care your plan covers? STAYING WELL Regence BlueCross BlueShield of Oregon is an Independent Licensee of the Blue Cross and Blue Shield Association Preventive Care Coverage Wondering what preventive care your plan covers? Our

More information

99381, 99382: Initial preventive medicine evaluation 99391, 99392: Periodic preventive medicine re-evaluation

99381, 99382: Initial preventive medicine evaluation 99391, 99392: Periodic preventive medicine re-evaluation Age Birth - 24 months 2-11 s M/ M/ Preventive medicine, re-, or office visit/ 8 visits within the first 24 months of life (As part of preventive medicine or re-, Hemoglobin, hematocrit, or CBC for those

More information

Chapter Three Accountable Care Organizations

Chapter Three Accountable Care Organizations Chapter Three Accountable Care Organizations One of the most talked-about changes in health care delivery in recent decades is Accountable Care Organizations, or ACOs. Having gained the attention of both

More information

Childhood Immunization Status (CIS)

Childhood Immunization Status (CIS) Childhood Immunization Status (CIS) Description The percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV); one measles, mumps and rubella

More information

Preventive Care Recommendations THE BASIC FACTS

Preventive Care Recommendations THE BASIC FACTS Preventive Care Recommendations THE BASIC FACTS MULTIPLE SCLEROSIS Carlos Healey, diagnosed in 2001 The Three Most Common Eye Disorders in Multiple Sclerosis Blood Pressure & Pulse Height & Weight Complete

More information

"2015 ACO quality measures- What's new? How can we be successful?"

2015 ACO quality measures- What's new? How can we be successful? "2015 ACO quality measures- What's new? How can we be successful?" ACO Announcements Reminders: ACO Notifications, Requests for Tax ID information from PECOS, Upcoming Boardline Upcoming Specialty Initiative

More information

Immunization Information for Blinn College Students

Immunization Information for Blinn College Students 1 Immunization Information for Blinn College Students *Important Information Regarding the Bacterial Meningitis Vaccine* The State passed Senate Bill 1107 in 2011 and recently Senate Bill 62 in 2013, which

More information

Preventive care services for commercial members

Preventive care services for commercial members Preventive care services for commercial members This schedule is a reference tool for planning your preventive care and lists items/services covered under the Patient Protection and Affordable Care Act

More information

Transient Hypogammaglobulinemia of Infancy. Chapter 7

Transient Hypogammaglobulinemia of Infancy. Chapter 7 Transient Hypogammaglobulinemia of Infancy Chapter 7 An unborn baby makes no IgG (antibody) and only slowly starts producing it after birth. However, starting at about the sixth month of pregnancy, the

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

Procedure Code(s): n/a This counseling service is included in a preventive care wellness examination or focused E&M visit.

Procedure Code(s): n/a This counseling service is included in a preventive care wellness examination or focused E&M visit. Coding Summary for Providers NOTE THE FOLLOWING: The purpose of this document is to provide a quick reference of the applicable codes for UnitedHealthcare plans that cover preventive care services in accordance

More information

Mid-Hudson Adherence to Antipsychotic Medications for People Living With Schizophrenia

Mid-Hudson Adherence to Antipsychotic Medications for People Living With Schizophrenia Adherence to Antipsychotic Medications for People Living With Schizophrenia 83 81 71 70 68 68 66 71 A. Behavioral Health 880 151 396 134 325 41 317 65 63 The percentage of recipients living with schizophrenia,

More information

See page 331 of HEDIS 2013 Tech Specs Vol 2. HEDIS specs apply to plans. RARE applies to hospitals. Plan All-Cause Readmissions (PCR) *++

See page 331 of HEDIS 2013 Tech Specs Vol 2. HEDIS specs apply to plans. RARE applies to hospitals. Plan All-Cause Readmissions (PCR) *++ Hospitalizations Inpatient Utilization General Hospital/Acute Care (IPU) * This measure summarizes utilization of acute inpatient care and services in the following categories: Total inpatient. Medicine.

More information

Health care reform update

Health care reform update Preventive services coverage Kaiser Foundation Health Plan of the Northwest has always offered broad, affordable coverage options that encourage members to seek care before a health condition becomes serious.

More information

Clinical HEDIS Medicare Stars Quick Reference Guide

Clinical HEDIS Medicare Stars Quick Reference Guide Clinical HEDIS Medicare Stars Quick Reference Guide MEASURE Adult BMI Assessment (ABA) Breast Cancer Screening (BCS) SPECIFICATIONS The percentage of members 18 74 years of age who had an outpatient visit

More information

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs MEDICARE FACT SHEET FOR IMMEDIATE RELEASE

More information

2012 Physician Quality Reporting System:

2012 Physician Quality Reporting System: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services R Official CMS Information for Medicare Fee-For-Service Providers 2012 Physician Quality : Medicare Electronic Health Record

More information

Clinical HEDIS Medicare Stars Quick Reference Guide

Clinical HEDIS Medicare Stars Quick Reference Guide Clinical HEDIS Medicare Stars Quick Reference Guide MEASURE Adult BMI Assessment (ABA) Breast Cancer Screening (BCS) SPECIFICATIONS The percentage of members 18 74 years of age who had an outpatient visit

More information

Premera 2016 HEDIS 1 (Healthcare Effective Data & Information Set) Coding and Documentation Guide

Premera 2016 HEDIS 1 (Healthcare Effective Data & Information Set) Coding and Documentation Guide Premera 2016 HEDIS 1 (Healthcare Effective Data & Information Set) Coding and Documentation Guide Measure Measure Description Protocol or Documentation Required Coding (AAB) Avoidance of Antibiotic Treatment

More information

LOEWENBERG SCHOOL OF NURSING LOEWENBERG SCHOOL OF NURSING HEALTH EXAMINATION FORM (FORM 003)

LOEWENBERG SCHOOL OF NURSING LOEWENBERG SCHOOL OF NURSING HEALTH EXAMINATION FORM (FORM 003) SECTION I: To be completed by STUDENT: Name: DOB: Address: Phone (H): Phone (C): Health History: Please complete the following information: Recent weight loss or gain Fatigue, fever, sweats Difficulty

More information

Provider Newsletter Molina Healthcare of California May 2013

Provider Newsletter Molina Healthcare of California May 2013 Provider Newsletter Molina Healthcare of California May 2013 Clinical Practice Guidelines (CPG) Update The Molina Healthcare of California Clinical Quality Improvement Committee (CQIC) annually reviews

More information

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary. http://www.cms.gov/ehrincentiveprograms/

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary. http://www.cms.gov/ehrincentiveprograms/ Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary 2010 What are the Requirements of Stage 1 Meaningful Use? Basic Overview of Stage 1 Meaningful Use: Reporting period

More information

http://www.ilga.gov/commission/jcar/admincode/077/077006650b0240...

http://www.ilga.gov/commission/jcar/admincode/077/077006650b0240... 1 of 5 7/30/2014 9:47 AM TITLE 77: PUBLIC HEALTH CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER i: MATERNAL AND CHILD HEALTH PART 665 CHILD HEALTH EXAMINATION CODE SECTION 665.240 BASIC IMMUNIZATION

More information

Manitoba EMR Data Extract Specifications

Manitoba EMR Data Extract Specifications MANITOBA HEALTH Manitoba Data Specifications Version 1 Updated: August 14, 2013 1 Introduction The purpose of this document 1 is to describe the data to be included in the Manitoba Data, including the

More information

Key Facts about Influenza (Flu) & Flu Vaccine

Key Facts about Influenza (Flu) & Flu Vaccine Key Facts about Influenza (Flu) & Flu Vaccine mouths or noses of people who are nearby. Less often, a person might also get flu by touching a surface or object that has flu virus on it and then touching

More information

PIDS AND RESPIRATORY DISORDERS

PIDS AND RESPIRATORY DISORDERS PRIMARY IMMUNODEFICIENCIES PIDS AND RESPIRATORY DISORDERS PIDS AND RESPIRATORY DISORDERS 1 PRIMARY IMMUNODEFICIENCIES ABBREVIATIONS COPD CT MRI IG PID Chronic obstructive pulmonary disease Computed tomography

More information

NCQA Health Insurance Plan Ratings Methodology March 2015

NCQA Health Insurance Plan Ratings Methodology March 2015 NCQA Health Insurance Plan Ratings Methodology March 205 REVISION CHART Date Published March 205 Description Final version (next update will be based on the 50% measure exclusion rule) TABLE OF CONTENTS

More information

Martin Portillo, MD Martin Portillo, MD, FACP Vice President Medical Affairs & Chief Medical Officer Molina Healthcare of Ohio

Martin Portillo, MD Martin Portillo, MD, FACP Vice President Medical Affairs & Chief Medical Officer Molina Healthcare of Ohio Dear Colleague, As an NCQA-accredited health plan, Molina Healthcare strives to meet Healthcare Effectiveness Data and Information Set (HEDIS ) requirements. HEDIS is regarded as the industry standard

More information

Pennsylvania School Immunization Requirements

Pennsylvania School Immunization Requirements Pennsylvania School Immunization Requirements The Commonwealth of Pennsylvania has minimum immunization requirements for all students. The Pennsylvania Department of Health states that for attendance in

More information

IHS Clinical Reporting System (BGP)

IHS Clinical Reporting System (BGP) RESOURCE AND PATIENT MANAGEMENT SYSTEM IHS Clinical Reporting System (BGP) Performance Measure List and Definitions Version 11.1 Office of Information Technology (OIT) Division of Information Resource

More information

Annually for adults ages 55 80 years with 30 pack/year smoking history and currently smoke or quit within the past 15 years Hepatitis B screening

Annually for adults ages 55 80 years with 30 pack/year smoking history and currently smoke or quit within the past 15 years Hepatitis B screening Preventive Care Schedule Effective January 1, 2016 Highmark Blue Cross Blue Shield Express Scripts The plan pays for preventive care only when given by a network provider. Certain vaccines are available

More information

IN-NETWORK MEMBER PAYS. Out-of-Pocket Maximum (Includes a combination of deductible, copayments and coinsurance for health and pharmacy services)

IN-NETWORK MEMBER PAYS. Out-of-Pocket Maximum (Includes a combination of deductible, copayments and coinsurance for health and pharmacy services) HMO-OA-CNT-30-45-500-500D-13 HMO Open Access Contract Year Plan Benefit Summary This is a brief summary of benefits. Refer to your Membership Agreement for complete details on benefits, conditions, limitations

More information

Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations

Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations VACCINE Table 1. Spanish Association of Paediatrics Immunisation Schedule. Recommendations of the Advisory Committee on Vaccines Age in months Age in years 0 2 4 6 12-15 15-18 2-3 4-6 11-12 Hepatitis B

More information

Health Information Form for Adults

Health Information Form for Adults A. IDENTIFICATION B. EMERGENCY CONTACTS Name (Last) (First) (Middle) Maiden Name Primary Alternate In Case of Emergency, Notify: Primary Contact Name (Last) (First) (Middle) Relationship Home Work Home

More information

Understanding preventive care

Understanding preventive care Understanding preventive care We want you to be your healthiest. That s why the preventive services listed here are free for most members. What services are recommended? Know before you go. Preventive

More information

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES Summary Table of Measures, Product Lines and Changes 1 SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES General Guidelines for Data Collection and Reporting Guidelines for Calculations and Sampling

More information

Coverage for preventive care

Coverage for preventive care Coverage for preventive care Understanding your preventive care coverage Preventive care, like screenings and immunizations, helps you and your family stay healthier and can help lower your overall out-of-pocket

More information

ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS

ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS The table below entitled Clinical Quality s for 2014 CMS EHR Incentive Programs for Eligible Professionals

More information

Stage 2 June 13, 2014

Stage 2 June 13, 2014 Stage 2 June 13, 2014 1 General Overview of Idaho Medicaid s EHR Incentive Program Stage 2 Meaningful Use (MU) Overview 2014 Reporting Helpful Resources 2 3 Medicaid can pay certain providers an incentive

More information

PROGRAM ASSISTANCE LETTER

PROGRAM ASSISTANCE LETTER PROGRAM ASSISTANCE LETTER DOCUMENT NUMBER: PAL 2012-03 DATE: April 11, 2012 DOCUMENT TITLE: Approved Uniform Data System Changes for 2012 TO: Health Center Program Grantees Primary Care Associations Primary

More information

Health Information Form for Adults

Health Information Form for Adults A. Identification B. Emergency Contacts Name (Last) (First) (Middle) Maiden Name In Case of Emergency, Notify: Primary Contact Name (Last) (First) (Middle) Primary Alternate Relationship Home Work Home

More information

Benefits and Covered Services

Benefits and Covered Services Section 4. Benefits and Covered Services This section provides an overview of the medical benefits and Covered Services for Molina Healthcare Members. There are some Member co-pays associated with services

More information

HEALTH CARE REFORM. Preventive Care. BlueCross BlueShield of South Carolina and BlueChoice HealthPlan of South Carolina

HEALTH CARE REFORM. Preventive Care. BlueCross BlueShield of South Carolina and BlueChoice HealthPlan of South Carolina HEALTH CARE REFORM Preventive Care BlueCross BlueShield of South Carolina and BlueChoice HealthPlan of South Carolina Preventive Care There was a time when an apple a day was the best preventive care advice

More information

Patient Centered Medical Home

Patient Centered Medical Home Patient Centered Medical Home 2013 2014 Program Overview Florida Blue is a trade name of Blue Cross and Blue Shield of Florida Inc., an Independent Licensee of the Blue Cross and Blue Shield Association.

More information

Preventive Care Coverage Wondering what preventive care your plan covers?

Preventive Care Coverage Wondering what preventive care your plan covers? STAYING WELL Regence BlueCross BlueShield of Oregon is an Independent Licensee of the Blue Cross and Blue Shield Association Regence BlueCross BlueShield of Oregon is an Independent Licensee of the Blue

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme

Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme Change to DENMARK S CHILDHOOD VACCINATION PROGRAMME 2014 Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme 2014 Addition to the Danish Health and Medicines

More information